http://www.mondaq.com/australia/x/523738/Patent/Experimental%2Bevidence%2Bin%2Bpatent%2Bcases%2BDiscovery%2Bnot%2Bavailable%2Bfor%2Bexperiments%2Bon%2Bmatters%2Bno%2Blonger%2Bin%2Bissue
https://www.thestreet.com/story/13693062/1/will-merck-mrk-stock-be-hurt-by-discontinuing-osteoporosis-drug-development.html
http://www.dailymail.co.uk/~/article-3770804/index.html
http://www.finanznachrichten.de/nachrichten-2016-09/38476037-merck-discontinues-its-odanacatib-development-program-020.htm

http://www.dailymail.co.uk/~/article-3770745/index.html
http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-Provides-Update-on-Odanacatib-Development-Program-22996139/
http://www.pmlive.com/pharma_news/roches_checkpoint_inhibitor_tecentriq_aces_lung_cancer_trial_1119404
http://www.4-traders.com//CIDARA-THERAPEUTICS-INC-21685642/news/CIDARA-THERAPEUTICS-INC-Termination-of-a-Material-Definitive-Agreement-Change-in-Directors-or-P-22991923/
http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-Study-Findings-on-Biotechnology-Are-Outlined-in-Reports-from-Merck-Company-High-density-m-22990720/
http://www.benzinga.com/general/biotech/16/09/8420417/merck-remains-stable-following-discontinuation-of-odanacatib-developme
https://www.thestreet.com/video/13693324/merck-to-discontinue-osteoporosis-drug-development.html
http://www.capital.fr/bourse/actualites/merck-co-abandonne-le-developpement-d-un-medicament-contre-l-osteoporose-1161059

http://www.ibtimes.com.au/greek-study-finds-statins-improve-erection-1527417
http://www.northjersey.com/cm/2.1593/news/business/merck-halts-development-of-osteoporosis-drug-due-to-stroke-risk-1.1653999
http://www.vancouversun.com/news/canada/isabel+wallace+make+sure+ebola+vaccine+canada+last+vaccine/12167502/story.html
http://www.proactiveinvestors.com/companies/news/147662/merck-axes-osteoporosis-treatment-odanacatib-147662.html
http://www.4-traders.com//POLR-CPTL-GLBL-HLTHCRE-GR-6306620/news/Polr-Cptl-Glbl-Hlthcre-Grth-Top-Ten-Equity-Holdings-and-Exposures-22997120/
http://www.zonebourse.com//actualite-bourse/MERCK-CO-abandonne-le-developpement-d-un-medicament-contre-l-osteoporose--22996861/
http://www.chemicalprocessing.com/articles/2016/light-replaces-ligands-for-synthesis/
http://www.mmm-online.com/media-news/mmms-top-5-stories-in-august-2016/article/519861/
http://www.newsamericasnow.com/obamas-america-episode-292-myth-making/
http://www.examiner.net/article/ZZ/20160901/BUSINESS/309019887/-1/business?rssfeed=true
http://www.4-traders.com//MERCK-CO-INC-13611/news/New-Data-from-Merck-Company-Illuminate-Findings-in-Bone-Resorption-Cathepsin-K-Inhibition-A-New-22991076/
http://www.economist.com/news/science-and-technology/21706240-how-anticipate-epidemics-putting-shots-locker
http://www.prnewswire.com/news-releases/crescita-therapeutics-inc-announces-acquisition-of-intega-skin-sciences-592006151.html
http://www.fool.com/investing/2016/09/01/pet-spending-is-soaring-should-you-buy-zoetis-inc.aspx?source=eptfxblnk0000004&utm_campaign=article&utm_medium=feed&utm_source=foxbusiness
http://www.wgmd.com/pet-spending-is-soaring-should-you-buy-zoetis-inc/

http://www.bloomberg.com/news/articles/2016-09-01/the-epipen-drama-shows-what-s-wrong-with-how-drugs-are-priced
http://www.humanosphere.org/global-health/2016/09/uganda-scores-major-victory-against-river-blindness-nears-eradication/
http://www.ssuchronicle.com/2016/09/02/cbcf-annual-health-and-wellness-luncheon-an-ounce-of-prevention-beats-a-pound-of-cure/
http://www.medpagetoday.com/InfectiousDisease/ZikaVirus/60009
http://www.finanznachrichten.de/nachrichten-2016-09/38477287-research-and-markets-foot-care-products-global-strategic-business-report-2022-leading-players-are-bazuka-compeed-daktarin-lamisil-at-scholl-008.htm


http://www.marketwatch.com/story/gelesis-appoints-new-chief-operating-officer-2016-09-02-215906

http://www.cbsnews.com/news/mylan-boosted-epipens-price-amid-bonus-target-for-execs/
http://www.free-press-release-center.info/pr00000000000000356413.html
http://knkx.org/post/how-worm-warriors-are-beating-unbeatable-worm
http://www.finanztreff.de/news/press-release-vaximm-appoints-dr-matthias-schroff-as-chief-executive-officer/11509533
http://www.mmm-online.com/roundup/five-things-for-pharma-marketers-to-know-friday-september-2-2016/article/520374/
